Keywords: s-p, completes, patient, enrollment, ph, iii, boceprevir

S-P completes patient enrollment in Ph III boceprevir study

Article | 09 February 2009

Print This

US drug major Schering-Plough has completed patient enrollment in the boceprevir HCV SPRINT-2 study, a pivotal Phase III trial in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in